// App-Quantinova.ai

BSH19‐PO‐110 : Validation of clinical‐grade whole genome sequencing reproduces cytogenetic analysis and identifies mutational landscape in newly‐diagnosed myeloma patients : a pilot study from the 100,000 Genomes Project

Researchers

Presenter

  • O. Lomas

Principal Investigators

  • M. Cabes

  • H. Dreau

  • E. Wilson

  • S. Gooding

  • K. Ramasamy

  • A. Hamblin

Medical Centers

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Fibroblast growth factor receptor

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

  • Syndecan-1

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved